Fidelity Emerging Markets -A ACC
The Emerging Markets Fund invests in liquid listed equity shares in emerging markets. The Fund is an actively managed concentrated portfolio (around 50 holdings). The fund tracks its performance against MSCI Emerging Markets Index (Net) since the Index constituent represents the type of companies it proposes to invest in. The investment process is fundamental and based on in-depth understanding of global value chains, and research by Fidelity’s large inhouse team. It invests at least 70% in markets experiencing rapid economic growth i.e. Latin America, South East Asia, Africa, Eastern Europe (including Russia) and the Middle East . The fund favours companies that exhibit strong & sustainable returns, good balance sheets and hold strong market position. The Fund also invests at least 30% in onshore China A and B Shares (directly or indirectly). It incorporates a bottom-up approach and tracks macroeconomic trends on a regular basis. The three sectors the portfolio is most exposed to are IT, Consumer Discretionary and Financials.
AB International Health Care Portfolio -A ACC
The Health Care fund invests in listed equity securities of health care & related companies (at least 80%) located throughout the world. It follows a fundamental bottom-up approach with a long-term view and based on high ROIC, strong cash flows & attractive valuation. A significant proportion of its allocation is to the US and the balance in other Developed Economies. It tends to go for large cap companies but may also invest in new treatments & biotechnology. It has less than 50 holdings and is Benchmarked to the MSCI World Health Care Index.
Allianz China Class A Shares AT Fund
The China A-shares fund invests at least 70% of its portfolio in China A-Shares, i.e. Mainland China’s domestic markets via the FII regime and the Stock Connect. Balance may be invested in related stocks such as China B/ H shares or other Emerging Markets. It is exposed to associated risks including RMB exchange rate volatility, changes in rule and regulations, capital controls, etc. The fund believes in fundamental analysis & active management and aims at long term capital growth to outperform its benchmark- the MSCI China A Onshore Total Return Index. The portfolio is well diversified across industry sectors. It is suitable for investors bullish on the Chinese stock markets.
United Global Quality Growth (USDHDG) ACC
The fund invests in equity and equity related securities of companies listed and traded on stock exchanges globally and is not constrained by market capitalisation, country, sector or industry. The companies it seeks to invest in typically have market capitalisation exceeding US$3 billion with sufficient trading volume. The fund employs a bottom-up investment approach to identify companies based on a balance of metrics such as quality, growth, valuation and capital returns.
Nikko AM Singapore Dividend Equity Fund
The Singapore Dividend Equity fund invests primarily in equities listed on the Singapore Stock Exchange offering attractive and sustainable dividend payments together with a potential for long term capital appreciation. The fund may also invest a small percentage in equities listed outside of Singapore with similar characteristics. The portfolio is structured to provide monthly distributions of 5-7% per annum, though investors may suffer short to medium term volatility in principal value. The fund has received multiple awards in the recent past and does not seek to outperform any benchmark.
This is a long only strategy which will primarily invest in global public equities listed in the United States. The strategy will aim to capture next generation businesses showing good growth, performance and fundamentals at a portfolio level. Though the strategy is sector and market capitalisation agnostic it may have a higher weightage to technology and large caps. This Kristal will construct and manage an optimally diversified portfolio of 10 -20 holdings as multi year investments that will thrive in the long term.
HK Equity Tech Stars
HK Equity Tech Stars is a fund strategy based on the mega trend towards digitalization. By 2021 it is expected that digital products and services in Asia amount up to 60% of GDP. To capitalize on this trend, the strategy invests predominantly in Hong Kong listed shares of companies in the digital technology space or other disruptive sectors. The initial selection of stocks is focused on 6 companies with a competitive advantage in their respective field, proven track record and strong growth momentum. Our Investment Committee is reviewing the list of constituents on a regular basis. New shares, either through IPO or secondary offerings may be added over time. Rebalancing of the stocks in the portfolio takes place once weighted allocation moves outside of a tolerance level determined by the IC. Baidu (9888 HK) was added to the portfolio in Apr 2021 after its HK listing was complete.